Trevena Reports Financial Results and Board ChangesOn November 5, 2024, Trevena, Inc. (NASDAQ: TRVN) issued a Form 8-K filing disclosing recent corporate developments. The pharmaceutical company announced several significant changes, including the re
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Trevena’s 8K filing here. Trevena Company Profile (Get Free Report) Trevena, Inc, a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. […]
More Stories
Where Food Comes From Reports Financial Results for Third Quarter of 2024
Where Food Comes From, Inc. (NASDAQ:WFCF) has released its financial results for the third quarter of 2024 through a recent...
ING Groep NV Buys 240,749 Shares of The Estée Lauder Companies Inc. (NYSE:EL)
ING Groep NV increased its stake in shares of The Estée Lauder Companies Inc. (NYSE:EL – Free Report) by 393.7%...
ING Groep NV Trims Stock Holdings in Ecolab Inc. (NYSE:ECL)
ING Groep NV lessened its stake in shares of Ecolab Inc. (NYSE:ECL – Free Report) by 3.8% in the 3rd...
iShares MSCI USA Quality Factor ETF (BATS:QUAL) Shares Bought by Palo Alto Wealth Advisors LLC
Palo Alto Wealth Advisors LLC grew its holdings in iShares MSCI USA Quality Factor ETF (BATS:QUAL – Free Report) by...
ING Groep NV Grows Stake in HashiCorp, Inc. (NASDAQ:HCP)
ING Groep NV boosted its holdings in shares of HashiCorp, Inc. (NASDAQ:HCP – Free Report) by 851.2% in the 3rd...
Boston Omaha (NYSE:BOC) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS
Boston Omaha (NYSE:BOC – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.05) earnings per...